Recommendations for investigation of hyperandrogenism.
1. Total testosterone assay is recommended as the first-line approach. 2. Radioimmunological assay following prior treatment of the sample (extraction or extraction + chromatography) is the recommended method pending wider experience with mass spectrometry. 3. Where testosterone is twice the upper limit of normal, it is recommended that DHEAS assay be performed. DHEAS is primarily of cortico-adrenal origin in women. Thus, a DHEAS level over 600 mg/dl indicates a diagnosis of androgen-secreting adrenal cortical adenoma.. If DHEAS is normal, the diagnosis could be either ovarian hyperthecosis, normally associated with insulin resistance, or androgen-secreting ovarian tumour. 4. More rarely, elevated testosterone is associated with a marked elevation of SHBG possibly as the result of use of medication having an estrogenic effect (tamoxifen, raloxifene, Op'DDD), or of hyperthyroidism or liver disease. 5. Normal testosterone levels in patients with clear clinical symptoms of hyperandrogenism (hirsutism, seborrhoeic acne) must be interpreted with care. SHBG is normally reduced in the event of overweight, metabolic syndrome or familial history of diabetes.
Pugeat
M
M
INSERM U863 IFR6, fédération d'endocrinologie, groupement hospitalier Est, hospices civils de Lyon, université Lyon-1, 59 boulevard Pinel, bâtiment Aile-A1, 7 Bron cedex, France.
Déchaud
H
H
Raverot
V
V
Denuzière
A
A
Cohen
R
R
Boudou
P
P
D000735:Androstenedione / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000503:physiopathology* / Q000628:therapy*; D007118:Immunoassay; D013058:Mass Spectrometry; D012016:Reference Values; D012107:Research Design; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D000735:Androstenedione; D019314:Dehydroepiandrosterone Sulfate